Navigation Links
Mr. Michel Bayouk resignation and passing
Date:6/2/2009

DENVER, CO, June 2 /PRNewswire-FirstCall/ - Medical International Technology Inc. (MDLH.PK) (http://www.mitcanada.ca http://www.mitinvest.ca), is sad to announce the passing of Mr. Michel Bayouk, our former Corporate Secretary, Principal Accounting Officer and Director.

On May 16th 2009, Mr. Michel Bayouk tendered his resignation from Medical International Technology Inc. as a Board member, secretary and principal accounting officer due to health related reasons.

June 1st 2009, Mr. Bayouk passed away at a Montreal hospital.

Mr. Bayouk had worked with Mr. Karim Menassa for over the past 25 years and had been working with Medical International Technology since its inception in 2001.

Mr. Bayouk will be remembered for his professionalism, honesty and most of all his heart of gold.

On behalf of all Medical International Technology's employees, shareholders, and myself, we send our deepest sympathies to his family.

Karim Menassa, President

On Behalf of the Board of Directors

Tel: 514-339-9355

About Medical International Technology, Inc. MIT CANADA, with offices in Montreal, is a subsidiary of Denver, Colorado-based Medical International Technology, Inc. (MIT USA), which specializes in the development, production, marketing and sale of needle-free injectors both for humans and animals, for individual and mass vaccinations.

The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development and acquisition of new product lines and services, government approval processes, the impact of competitive products or pricing a technological ch
'/>"/>

SOURCE MEDICAL INTERNATIONAL TECHNOLOGIES INC.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Clarient Names Michele Hibbard, Ph.D. Director of Genetics
2. Biodel Inc. Announces Appointment of Gerard Michel as CFO, VP of Corporate Development and Treasurer
3. Vincent J. Milano to Succeed Michel de Rosen as President and Chief Executive Officer of ViroPharma
4. Michel Nakache Returns to Euro RSCG Life as Worldwide Managing Partner
5. Campaign for Tobacco-Free Kids Honors Michelle Mays of Rhinelander, WI As Youth Advocate of the Year
6. Fitness and Figure Professionals Kirsten Nicewarner and Michelle Adams to Represent GNC at Vails Teva Mountain Games
7. Its A Merry Christmas for Baby John After Mother Michelles Life-Saving Transplant
8. Michelle Worrall Tilton to Speak at Annual American Bar Association Forum on Communications Law
9. Fashion Designer Naeem Khan, Actor Richard Kind and Star Chef Michel Nischan Among Other Luminaries to Attend Diabetes Research Institute Foundations D.R.E.a.M.S. in the City
10. Sally Field, Phil and Jan Fenty, and Michelle King Robson to Be Honored at Benefit for Osteoporosis and Bone Health Awareness
11. AIDS Healthcare Foundation Applauds City Commissioners Support of Diversity, Urges Call for Mayors Resignation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... Trust Inc. (NYSE: CRE ) ("Care" or the ... dividend of $0.17 per share of common stock. The dividend ... on December 14, 2009. ,, About Care ... estate investment and finance company investing in healthcare-related real estate and ...
(Date:12/4/2009)... Medithrive, Inc. has won the Patient,s Choice Award ... by popular vote conducted by the online website, ... SF Bay community has selected Medithrive as the preeminent ... rapid rise and popularity of Medithrive confirms the obvious: ...
(Date:12/4/2009)... Dec. 4 The American Association of Homes and Services ... the Community Living and Supportive Services (CLASS) provisions remain ... are essential for providing support to elders, people with disabilities ... pass a health care reform bill that will make it ...
(Date:12/4/2009)... The large, two-day free health clinic sponsored by the ... Wednesday and Thursday is not just for the sick but ... a doctor recently. All participants in the health clinic will ... the three previous large free clinic events this fall in ...
(Date:12/4/2009)... Dec. 4 Pamela Bowen, Chief Information Officer at ... "Chief Innovation Officer" Appy Award for transforming Crescent,s business ... are nominated based on their innovative usage of Salesforce ... of customer success to their sales, marketing, partner, service, ...
Breaking Medicine News(10 mins):Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2
... sleep patterns in a type of anesthesia that are ... The anesthetic used in the study, known as ethyl ... more thoroughly investigate ways of treating sleep disorders and ... the studys co-authors and an associate professor of psychology, ...
... Md., April 16, 2008 The U.S. Pharmacopeial ... Program participants. USP is the official standards-setting body ... States. It also sets standards that are widely ... dietary supplements. USPs internship program offers the opportunity ...
... A California Superior Court,today issued a temporary restraining ... Stern and SEIU to cease and desist the,stalking ... officers,directors, and staff of the California Nurses Association/National ... Stern are prohibited from stalking,threatening, or following CNA/NNOC ...
... April 16 Do you know anyone,who,s a ... take personality tests, the cranberry would turn out ... in these little red gems. But the antioxidants,deserve ... ), Often identified in food by their ...
... weekend faced 13.4% lower chance of recovery, study finds , , ... a cardiac arrest are 13.4 percent worse if you are ... according to new research. , Even after taking into account ... age, gender and other illnesses, the lower survival rate remains ...
... around our middle could be making us hungrier, so we ... fat. Dr. Yaiping Yang and his colleagues at the ... Ontario found abdominal fat tissue can reproduce a hormone that ... will change in the way we think about and treat ...
Other Medicine News:Health News:USP announces 2008 summer internship program participants 2Health News:Court Orders Service Union and Its President Andy Stern: Stop Stalking and Harassing Registered Nurse Leaders and Staff of California Nurses Assn/NNOC 2Health News:Court Orders Service Union and Its President Andy Stern: Stop Stalking and Harassing Registered Nurse Leaders and Staff of California Nurses Assn/NNOC 3Health News:Cranberries: The Little Fruit With a Great Big Punch 2Health News:Cranberries: The Little Fruit With a Great Big Punch 3Health News:Your belly fat could be making you hungrier 2
(Date:12/4/2009)... The U.S. Food and Drug Administration (FDA) ... option for the treatment of schizophrenia and manic or ... aged 13-17 years old. ,, The updated Zyprexa ... increased potential for weight gain and hyperlipidemia in adolescents ...
(Date:12/4/2009)... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today ... webcast. Principal investigators will discuss the data presentations ... featured at the 51st American Society of Hematology (ASH) ... a.m. CT/10:00 a.m. ET on Monday, December 7, 2009. ...
(Date:12/4/2009)... Chemistry World recently highlighted a new report ... America ( PhRMA ) that identifies 97 new drugs ... The report found that the 97 products in ... either in human clinical trials or awaiting approval by the ...
Breaking Medicine Technology:FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2InteKrin Therapeutics Presents Positive Long Term INT131 Preclinical Cardiovascular Safety Data at the 45th Annual European Association for the Study 5085 1InteKrin Therapeutics Presents Positive Long Term INT131 Preclinical Cardiovascular Safety Data at the 45th Annual European Association for the Study 5085 2Clipa for a Cure 3A New Pink Instant Handbag Hanger Benefits Breast Cancer Research 58508 1Clipa for a Cure 3A New Pink Instant Handbag Hanger Benefits Breast Cancer Research 58508 2BASF Podcast 3A The Chemical Reporter Why Does Fluoride Make Your Teeth Hard 3F 58504 1BASF Podcast 3A The Chemical Reporter Why Does Fluoride Make Your Teeth Hard 3F 58504 2BASF Podcast 3A The Chemical Reporter Why Does Fluoride Make Your Teeth Hard 3F 58504 3
... Survival vs. Interferon-Alpha, COLLEGEVILLE, Pa., Nov. 26 ... WYE ), announced today that the,European Commission has ... with advanced renal cell carcinoma (RCC),who have at ... is the only,approved cancer therapy that specifically inhibits ...
... VioQuest,Pharmaceuticals (OTC Bulletin Board: VQPH) today ... of Lenocta(TM) (sodium stibogluconate), a novel,protein tyrosine ... immune stimulant approved for the treatment of ... cancers. The open-label Phase IIa study is,designed ...
Other Medicine Technology:Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer 2Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer 3Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer 4Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer 5Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer 6VioQuest Pharmaceuticals Announces Dosing of First Patient in Phase IIa Solid Tumor Study for Lenocta(TM), a Novel Protein Tyrosine Phosphatase Inhibitor 2VioQuest Pharmaceuticals Announces Dosing of First Patient in Phase IIa Solid Tumor Study for Lenocta(TM), a Novel Protein Tyrosine Phosphatase Inhibitor 3VioQuest Pharmaceuticals Announces Dosing of First Patient in Phase IIa Solid Tumor Study for Lenocta(TM), a Novel Protein Tyrosine Phosphatase Inhibitor 4
The APR Hip System offers a complete line of stems to precisely match patients' anatomic needs and address surgeon preferences....
The APR Hip System offers a complete line of stems to precisely match patients' anatomic needs and address surgeon preferences....
Dual offset femoral stems, hip stems that provide unique and competitive features....
Cementless hip stem revisions offering optimal version setting for each patient. Compatible with modular link ceramic or cobalt chromium femoral heads with up to 4 neck lengths, or the link saddle de...
Medicine Products: